Please note: This is a Sole Source Notification. The procurement is for BioFire Defense LLC (BioFire) test kits, reagents, and associated consumables required for rapid molecular diagnostic testing. Additionally, the purchase includes software, maintenance, and technical support services necessary for the operation and upkeep of BioFire systems already owned by IDPH. BioFire FilmArray is the only one with publicly available documentation confirming its approval for use within the LRN. No published sources explicitly state that the other systems are not LRN-approved; instead, there is an absence of documentation from the CDC confirming their approval. • Only FDA EUA-approved system for LRN-based Ebola virus detection. • Only system integrating Global Fever Panel pathogens in a single test workflow. • Fully automated, closed-cartridge system to reduce contamination risk. • Regulatory compliance with CDC and IDPH biosafety requirements (BSL-3 testing for Ebola, BSL-2 screening for malaria and other pathogens) .• Provided solely with maintenance, software, and extended warranties, ensuring operational readiness. Alternative systems were considered but found unsuitable due to lack of CDC/DoD approval, incompatibility with IDPH's existing infrastructure, and failure to meet biosafety and regulatory requirements. Alternative vendors considered: Cepheid, altona Diagnostics, and OraSure Technologies.
